Theravance Biopharma Inc reports results for the quarter ended in December - Earnings Summary

Theravance Biopharma

26/02/2024 22:38

* Theravance Biopharma Inc  TBPH.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -15 cents.  The mean expectation of three analysts for
the quarter was for a loss of 15 cents per share. Wall Street
expected results to range from -24 cents to -5 cents per share.
    * Revenue rose 19.9% to $17.57 million from a year ago;
analysts
expected $17.68 million. 
    * Theravance Biopharma Inc's reported EPS for the quarter
was a
loss of 17 cents​.
    * The company reported a quarterly loss of $8.51 million.
    * Theravance Biopharma Inc shares had fallen by 20.1% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Theravance
Biopharma Inc is $12.50 
This summary was machine generated from LSEG data February 26 at
10:38 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.15          -0.17          Missed
 Sep. 30 2023      -0.21          -0.17          Beat
 Jun. 30 2023      -0.21          -0.28          Missed
 Mar. 31 2023      -0.25          -0.35          Missed